Chime Financial Slides as Recent Insider Sales Likely Weigh on Shares

Chime Financial, Inc. (CHYM) is down 7.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst appears to be continued pressure from recent insider and major-holder stock sales rather than a fresh negative company announcement today. This could also be because investors are reassessing valuation after recent corporate updates, including Chime’s planned bank acquisition, while a wave of selling by large holders adds near-term supply to the stock.

Details:

SEC Form 4 filings showed entities affiliated with DST Global, a more-than-10% holder, sold about 3.2 million CHYM shares on September 14, 2026, at weighted average prices around the mid-$34 range.

A separate SEC Form 4 showed director James Feuille sold 447,637 shares through affiliated entities between September 14 and September 16, 2026.

Chime announced on September 8, 2026 that it agreed to acquire Stride Bank for $590 million in cash, a deal it said should be immediately accretive to earnings and deliver more than $100 million in net synergies.

With no obvious new negative operating update on the company’s investor site today, the drop looks more consistent with selling overhang and profit-taking after a period of active corporate news and prior optimism around growth and strategy.

Sources:

SEC, Chime Investor Relations, Benzinga

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CHYM Insider Trading Activity

$CHYM insiders have traded $CHYM stock on the open market 320 times in the past 6 months. Of those trades, 0 have been purchases and 320 have been sales.

Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:

GLOBAL ADVISORS LTD DST has made 0 purchases and 280 sales selling 32,500,244 shares for an estimated $1,070,388,468.
JAMES FEUILLE has made 0 purchases and 10 sales selling 799,527 shares for an estimated $26,335,559.
CHRISTOPHER R BRITT (Chief Executive Officer) has made 0 purchases and 10 sales selling 850,000 shares for an estimated $26,271,578.
SHAWN T CAROLAN has made 0 purchases and 6 sales selling 579,313 shares for an estimated $19,194,539.
RYAN A KING (Co-Founder) has made 0 purchases and 4 sales selling 417,421 shares for an estimated $12,841,242.
ADAM B FRANKEL (General Counsel) has made 0 purchases and 4 sales selling 108,002 shares for an estimated $3,504,105.
MATTHEW S NEWCOMB (Chief Financial Officer) has made 0 purchases and 2 sales selling 65,000 shares for an estimated $1,961,000.
AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 4 sales selling 39,505 shares for an estimated $1,192,529.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CHYM Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CHYM Hedge Fund Activity

We have seen 178 institutional investors add shares of $CHYM stock to their portfolio, and 122 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ICONIQ CAPITAL, LLC removed 11,064,137 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $226,593,525
COATUE MANAGEMENT LLC removed 10,071,992 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $206,274,396
BLACKROCK, INC. added 9,819,060 shares (+688.9%) to their portfolio in Q2 2026, for an estimated $201,094,348
TIGER GLOBAL MANAGEMENT LLC removed 8,908,454 shares (-62.8%) from their portfolio in Q2 2026, for an estimated $182,445,137
POINT72 ASSET MANAGEMENT, L.P. removed 4,586,956 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $85,913,685
SCGE MANAGEMENT, L.P. removed 4,181,827 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $85,643,816
CITADEL ADVISORS LLC removed 3,709,869 shares (-55.9%) from their portfolio in Q1 2026, for an estimated $69,485,846

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CHYM Price Targets

Multiple analysts have issued price targets for $CHYM recently. We have seen 5 analysts offer price targets for $CHYM in the last 6 months, with a median target of $28.0.

Here are some recent targets:

Nik Cremo from Barclays set a target price of $26.0 on 07/08/2026
Joseph Vafi from Canaccord Genuity set a target price of $40.0 on 05/11/2026
Cassie Chan from Wells Fargo set a target price of $28.0 on 05/07/2026
Andrew Bauch from BMO Capital set a target price of $30.0 on 04/22/2026
Giuliano Bologna from Compass Point set a target price of $27.0 on 04/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.